Soligenix, Inc.(SNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据

Soligenix, Inc.(SNGX)

盘后0.39990.01+2.54%19:13 EDT

0.3900+0.0265+7.29%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
Soligenix, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.soligenix.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Soligenix, Inc.是一家临床阶段生物制药公司，成立于1987年，专注于开发产品，治疗癌症和严重的胃肠道疾病的治疗所产生的危及生命的副作用（仍然是一个未满足的医疗需求），以及开发多种生物防御疫苗和疗法。
- 05-10
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 04-22
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 04-16
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 04-15
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 04-04
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 04-03
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 04-03
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 04-03
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 04-02
  [修订]招股说明书
  Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
  Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
- 03-15
  [修订]招股说明书
  Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
  Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
- 03-15
  年度报告
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 01-16
  招股说明书
  Form S-1 - General form for registration of securities under the Securities Act of 1933
  Form S-1 - General form for registration of securities under the Securities Act of 1933
- 2023-12-22
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2023-12-15
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2023-12-15
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence